Serum levels of S100B and NSE proteins in Alzheimer's disease patients - Wikidata - wikimedia - TriplyDB

Serum levels of S100B and NSE proteins in Alzheimer's disease patients

Serum levels of S100B and NSE proteins in Alzheimer's disease patients

http://www.wikidata.org/entity/Q33705590

about

Association between S100B Levels and Long-Term Outcome after Aneurysmal Subarachnoid Hemorrhage: Systematic Review and Pooled Analysis cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases.The S100B protein in biological fluids: more than a lifelong biomarker of brain distress.Neuroprotective role of γ-enolase in microglia in a mouse model of Alzheimer's disease is regulated by cathepsin X.PSAPP mice exhibit regionally selective reductions in gliosis and plaque deposition in response to S100B ablation.Plasma proteins predict conversion to dementia from prodromal disease Neuroprotective Effect of Uncaria rhynchophylla in Kainic Acid-Induced Epileptic Seizures by Modulating Hippocampal Mossy Fiber Sprouting, Neuron Survival, Astrocyte Proliferation, and S100B Expression.Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer disease.S100B blood levels and childhood trauma in adolescent inpatients S100B-p53 disengagement by pentamidine promotes apoptosis and inhibits cellular migration via aquaporin-4 and metalloproteinase-2 inhibition in C6 glioma cells.Use of Tethered Enzymes as a Platform Technology for Rapid Analyte Detection.Epigenetic profiling of human brain differential DNA methylation networks in schizophrenia.Overweight and obesity are associated with neuronal injury in the human cerebellum and hippocampus in young adults: a combined MRI, serum marker and gene expression study.The unique alterations of hippocampus and cognitive impairment in chronic obstructive pulmonary disease.S100B protein in neurodegenerative disorders.Investigation of phosphoproteome in RAGE signaling.Sterile Neuroinflammation and Strategies for Therapeutic Intervention Evaluation of dietary and lifestyle changes as modifiers of S100β levels in Alzheimer's disease.Elevated levels of cerebrospinal fluid S100B are associated with brain injury and unfavorable outcomes in children with central nervous system infections.Correlation between serum S100β protein levels and cognitive dysfunction in patients with cerebral small vessel disease: a case-control study.Thermodynamic and kinetic analysis of peptides derived from CapZ, NDR, p53, HDM2, and HDM4 binding to human S100B Novel interactions of the TRTK12 peptide with S100 protein family members: specificity and thermodynamic characterization.The S100B/RAGE Axis in Alzheimer's Disease.Voltammetric detection of S100B protein using His-tagged receptor domains for advanced glycation end products (RAGE) immobilized onto a gold electrode surface Influence of the blood-CSF-barrier function on S100B in neurodegenerative diseases.Serum S100B level increases after running but not cycling exercise.Increased expression of Beclin-1-dependent autophagy protects against beta-amyloid-induced cell injury in PC12 cells [corrected].Effects of chronic guanosine treatment on hippocampal damage and cognitive impairment of rats submitted to chronic cerebral hypoperfusion.Is serum S100B protein an useful biomarker in migraine?The Effect of Mechanical Ventilation on TASK-1 Expression in the Brain in a Rat Model.Association between serum neuron-specific enolase, age, overweight, and structural MRI patterns in 901 subjects.Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?S100β is associated with cognitive impairment in childhood-onset systemic lupus erythematosus patients.New Insights into the Role of Neuron-Specific Enolase in Neuro-Inflammation, Neurodegeneration, and Neuroprotection.S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain.Subchronic oral administration of Benzo[a]pyrene impairs motor and cognitive behavior and modulates S100B levels and MAPKs in rats.Relationships between markers of neurologic and endothelial injury during critical illness and long-term cognitive impairment and disability.The neuroprotective and anti-apoptotic effects of melatonin on hemolytic hyperbilirubinemia-induced oxidative brain damage.Metabolic Derangements Contribute to Reduced sRAGE Isoforms in Subjects with Alzheimer's Disease.Longitudinal serum S100β and brain aging in the Lothian Birth Cohort 1936

P2860

Q26752317-A001C69A-C68E-4A23-941F-81DD5817E8F0 Q34155662-9DF7048E-79F0-4F77-9342-74ABFE3EAC71 Q34238722-8BE67B64-29EA-43CF-8E65-05EE662797C5 Q34341462-E444659E-188D-41E3-B6BE-1C0504FF912A Q34376145-79C02EEF-78CA-4604-B7A5-D066CEA28311 Q34556953-1B93CE45-E199-4F4B-8A69-2DB5DA8F8C86 Q35151612-7E714549-78FA-4384-8E7B-926FF141C7BD Q35158065-8443FCD1-1E4F-47CA-BD6C-4FE81078EF45 Q35551126-16A62996-A78C-4E2D-BE57-8BDF7CCBDB57 Q35681474-9631FC57-3ED0-4EA8-9595-F60076E1A33E Q35852229-A601EAA6-0EE5-4243-BA75-96D773038572 Q36258528-E2AAE7B4-606B-4E78-802F-BF88546CACC0 Q36589661-02890004-E60E-445C-9865-9D5929BA60F5 Q37425324-0330CF90-25D8-4107-B06D-F32EE41B1015 Q37837904-E9791F68-1365-46AA-B023-435B7B089710 Q38260264-28CC5302-70D2-4346-9D63-B5CF53911519 Q39105980-74871647-4DAB-41BA-9FBB-976C14320C1E Q39428145-147F1555-CFD1-4A80-8107-A536B3256DEE Q40854865-1948908C-269C-4D8D-96FF-D7CCC9BFDB8D Q41046732-CD6A53CB-B92D-4322-AF72-5D5C9E62A620 Q41915588-01585DF5-A90B-4919-B7E9-DD54475829B1 Q42128457-C085E2B0-DD68-49C2-A518-C2224933B760 Q42151789-451D3A4E-A543-46A6-96AF-DC53D2053C3E Q42762235-E64E593C-1684-4580-9243-9D2F0DB49E77 Q44180584-CA52AFCE-14C4-4834-BF7C-DD9D59D8509E Q45155002-39DF961D-984C-4DEC-9A4A-7D3756B70F68 Q45281694-9B3F9A47-AE61-4C9C-B96A-5F58B7239303 Q45325730-C536A9C5-5FC5-4C9C-A740-A392AE1B59AE Q45835677-C84BDA0D-97F6-48F5-9258-56282F3D4978 Q47098159-9D13C53F-03E0-44EF-9A01-88D860DD058A Q47927312-9573E3AF-B38B-43BC-BA3F-835480E70338 Q48079168-D667E024-6273-48C8-B034-B9FA720EC317 Q48667106-1D018A15-4BE6-4801-A9DE-A42B002C19A2 Q49804316-1BE95C26-462E-45A2-99A4-046978236744 Q50000872-D181FC72-44FF-4440-B620-514D22AE6EAB Q50858926-8D0DBD89-E838-4581-82DE-EA8E08A64743 Q51764415-272BD3A0-7EB0-41BB-ACA6-90F6D3EA9AE7 Q52147437-43BDA85F-7411-461A-B16A-D30A977B0D39 Q55039717-C6598761-3B6D-4CEF-90C1-31E5E963385B Q56992670-C210F6E3-F4C0-4976-B9FA-48F70D0386F1

P2860

Serum levels of S100B and NSE proteins in Alzheimer's disease patients

http://www.wikidata.org/entity/Q33705590

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Serum levels of S100B and NSE proteins in Alzheimer's disease patients

@ast

Serum levels of S100B and NSE proteins in Alzheimer's disease patients

@en

type

label

Serum levels of S100B and NSE proteins in Alzheimer's disease patients

@ast

Serum levels of S100B and NSE proteins in Alzheimer's disease patients

@en

prefLabel

Serum levels of S100B and NSE proteins in Alzheimer's disease patients

@ast

Serum levels of S100B and NSE proteins in Alzheimer's disease patients

@en

P1433

Q33705590-A29BFBD3-71C5-49EB-9291-6AFC150D4667

P1476

Q33705590-B2DA091B-7CD2-41D7-B697-AF8BFE97F96A

P2093

Q33705590-230F3CC4-249B-4829-92AB-7D712FCBD31C

Q33705590-42DFB9F1-DDAE-496C-8448-78C718E127D8

Q33705590-494C7395-2DD7-47AE-8288-A00B7FBC5C44

Q33705590-617DCD8A-AB92-4E85-A03C-B6C9D4EED446

Q33705590-78A20CFE-7C96-4A85-9025-6BBA3A9A8913

Q33705590-D7E96574-6D35-4BC2-8B0D-4E940737BAE4

Q33705590-F66E998A-A03B-4F86-94F9-D36B1D8211E1

P2860

Q33705590-03D23084-0818-4EFB-B2C0-3438285EA7D7

Q33705590-0909FC55-89B0-4F52-8DC1-6A3AC8E4A86F

Q33705590-0FCABBF5-36F8-4C9D-A7DF-F1E29006799F

Q33705590-174919B2-10F9-4E09-BE28-47DC68EE4365

Q33705590-18CC215C-DC84-4083-A1BD-C9B060981EAE

Q33705590-1F8139A0-A127-4C61-8CDD-3BEE0946C3A6

Q33705590-20EF669F-B086-4848-BCC0-C44660841037

Q33705590-35B776C9-ABF6-4392-B610-EFE889A11B3D

Q33705590-389D40BE-1CB2-44B5-A804-AF4E22EC9F2F

Q33705590-3DD5EFAE-D268-47AB-A8FF-93E59F1F13FE

P2888

Q33705590-2BD01B0D-B103-4BFB-8E99-213A8E5EB116

P304

Q33705590-7CEAB42C-46CB-43A3-9EAD-55C10B1155E7

P31

Q33705590-F6DFE5F4-94C5-4A82-B197-5365381FC1E5

P356

Q33705590-A2127B99-38DA-4DFF-9901-0D7DD3E39ED0

P478

Q33705590-427A4366-033E-430E-8B7A-4CEA8A96E3C8

P50

Q33705590-3B83E617-4025-4439-BAE7-E1C83E80BEE7

Q33705590-C4707B1A-249A-4E3F-A905-2173050203C1

P577

Q33705590-51B66EF4-0BE9-4E06-90EF-040002E69060

P5875

Q33705590-3A9DAA20-9C1F-4946-BEF4-96E158BEEC11

P6179

Q33705590-543019BF-1AE0-4F30-9D30-AC5878BE72FA

P698

Q33705590-6A02D3A1-48CD-441A-AF3B-B86E65C034E6

P921

Q33705590-DB33A136-5599-4B19-A8C2-2BB2FCDB6D0D

P932

Q33705590-65648C95-580E-471D-B848-3092B48DD423

P356

P1433

Journal of Neuroinflammation

P1476

Serum levels of S100B and NSE proteins in Alzheimer's disease patients

@en

P2093

Ana L Camozzato

http://www.w3.org/2001/XMLSchema#string

Eduardo D Ferreira

http://www.w3.org/2001/XMLSchema#string

Guilherme S Mazzini

http://www.w3.org/2001/XMLSchema#string

Isabel Piazenski

http://www.w3.org/2001/XMLSchema#string

Luis V Portela

http://www.w3.org/2001/XMLSchema#string

Márcia L Chaves

http://www.w3.org/2001/XMLSchema#string

Oscar Dall'Igna

http://www.w3.org/2001/XMLSchema#string

P2860

Survival after Initial Diagnosis of Alzheimer Disease

Alzheimer Disease in the US Population

Cerebrospinal fluid enolase in stroke

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neurological outcome after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme analysis

Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease

Biomarkers of Alzheimer disease.

The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease.

Alzheimer disease and cerebrovascular pathology: an update.

P2888

P304

6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-2094-7-6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Renata Kochhann

P577

2010-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41164333

http://www.w3.org/2001/XMLSchema#string

P6179

1003848850

http://www.w3.org/2001/XMLSchema#string

P698

20105309

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2832635

http://www.w3.org/2001/XMLSchema#string